Ethics of insurance-driven barriers to biologic therapy in hidradenitis suppurativa
Journal of the American Academy of Dermatology · 2026-08 · 95 (2) · e105-e106
DOI: 10.1016/j.jaad.2026.02.121 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-08. Verfasst von Esther O Nwozo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Dermatology, University of Iowa, Iowa City, Iowa. Elect…. Die Arbeit nennt 5 Literaturangaben.
Themen: Ethik in der Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; Department of Dermatology, University of Iowa, Iowa City, Iowa. Electronic address: esther.nwozo@temple.edu.
- Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
- Department of Dermatology, University of Iowa, Iowa City, Iowa.
Zitieren
APA
Nwozo, E. O., Onuoha, C., & Negbenebor, N. A. (2026). Ethics of insurance-driven barriers to biologic therapy in hidradenitis suppurativa. Journal of the American Academy of Dermatology, 95(2), e105-e106. https://doi.org/10.1016/j.jaad.2026.02.121
Vancouver
Nwozo EO, Onuoha C, Negbenebor NA. Ethics of insurance-driven barriers to biologic therapy in hidradenitis suppurativa. Journal of the American Academy of Dermatology. 2026;95(2):e105-e106. doi:10.1016/j.jaad.2026.02.121
BibTeX
@article{Nwozo2026,
author = {Nwozo, Esther O and Onuoha, Chiebuka and Negbenebor, Nicole A},
title = {Ethics of insurance-driven barriers to biologic therapy in hidradenitis suppurativa},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {2},
pages = {e105--e106},
doi = {10.1016/j.jaad.2026.02.121}
}
EUVIMED